Table 2 Expression in other normal, tumor biopsies and cell lines by differential RT-PCR
From: Identification and characterization of a novel nasopharyngeal carcinoma-associated peptide: NAP-1
case number & specimen | IA | case number & specimen | IA |
|---|---|---|---|
1 tonsil | 0.78 | 2 lymph node | 1.00 |
3 tonsil carcinoma | 0.45 | 4 T- cell lymphoma | 0.86 |
5 tongue root lymphoma | 0.35 | 6 hard palate squamous cell carcinoma | 0.39 |
7 nasopharynx papilloma | 0.17 | 8 chronic nasopharyngitis | 0.59 |
9 follicular dendritic cell line | 1.02 | 10 chronic inflammation of vocal cords | 0.00 |
11 larynx carcinoma | 0.00 | 12 epiglottis carcinoma | 0.00 |
13 hypopharynx carcinoma | 0.00 | 14 cerebra | 0.00 |
15 glioma | 0.00 | 16 ileum | 0.00 |
17 liver, liver cancer | 0.00 | 18 kidney | 0.00 |
19 stomach, stomach cancer | 0.00 | 20 parotid, spleen | 0.00 |
21 fetal heart, uterus | 0.00 | 22 rectum, rectal cancer | 0.00 |
23 CNE-1 | 0.00 | 24 CNE-2 | 0.00 |
25 HNE-3 | 0.00 | 26 5–8F | 0.00 |